Investigation of Serum Oxidized Low-Density Lipoprotein IgG Levels in Patients with Angiographically Defined Coronary Artery Disease

Table 4

Association between serum anti-oxLDL titres and CVD risk factors in stepwise multiple regression analysis.

Covariate	𝛽	𝑃	95% confidence interval
Age	−.162	.616	−.096–0.60
FBS	.402	.290	−.007–0.020
LDL-C	.090	.759	−.021–0.028
HDL-C	−.290	.349	−.085–0.034
TG	.005	.990	−.016–0.016
SBP	.136	.693	−.022–0.031
DBP	−.388	.389	−.099–0.043
DM	.227	.546	−1.676–2.938
Smoking	.105	.699	−.482–0.684
HTN	.360	.275	−.720–2.210
HLP	−.123	.592	−1.337–0.815
BMI	−.651	.615	−.599–0.378
Waist hip ratio	−2.085	.430	−105.209–49.503

FBS: fasting blood sugar; BMI: body mass index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension; HLP: hyperlipidemia; BMI: body mass index.